MUMBAI, India, March 13 -- Intellectual Property India has published a patent application (202621006847 A) filed by Indian Institute Of Technology, Maharashtra, on Jan. 23, for 'identification of lipid signature molecules indicative of comorbid conditions in a covid-19 subject.'
Inventor(s) include Vaishali Singh; Amit Karmakar; and Sanjeeva Srivastava.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The proposed invention provides an in vitro method for identifying lipid signature molecules in serum samples from COVID-19 subjects with and without pre-existing metabolic disorders. The method includes obtaining serum samples from COVID-19 subjects with and without pre-existing metabolic disorders. Further, the method includes extracting lipids from the serum samples and analyzing the lipid extracts using at least one of high-resolution mass spectrometry (HRMS), liquid chromatography-mass spectrometry (LCMS), and a targeted lipidomic platform. The targeted lipidomic platform determines lipid classes by analyzing the dried lipid extracts and identifies lipid signatures by comparing the lipid profiles of the serum samples from the COVID-19 subjects with and without pre-existing metabolic disorders. This comparison using the targeted lipidomics platform determines specific lipid signatures based on the lipid classes."
Disclaimer: Curated by HT Syndication.
